Twice-a-year (paid) PrEP study (New York) - (20)

HPTN 102-PURPOSE 3 is a clinical study being done to see whether an investigational twice-a-year injection medicine can help reduce the risk of getting HIV from sex. Could I Qualify? -You're 18 and older -You're a cisgender woman and you've been sexually active with a cisgender man in the last 12 months -You haven't received a positive HIV test -You have not been on long-acting PrEP For more information, please call/ text 917-841-4125 ICAP Harlem Prevention Center- Columbia University 215 West 125th Street, Suite 302 New York, NY 10027 https://www.purposestudies.com/purpose3/ https://icap.columbia.edu/where-we-work/harlem/